Apollo Hospitals Q1 Review - Strong Revenue Growth; Focus On Digital Network: ICICI Securities
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Apollo Hospitals Enterprise Ltd.’s Q1 FY22 performance was better than estimate led by strong recovery in occupancies along with average revenue per occupied bed, stock piling by pharmacy customers during second Covid-19 wave and incremental revenue from vaccination.
However, margins were low due to lower margins in vaccination business and costs relating to 24x7 initiative.
Overall, revenues grew 73.2% YoY to Rs 37.6 billion (our estimate: Rs 31.4 billion).
We remain positive on Apollo Hospitals’ long-term outlook considering its strong brand and pan-India presence in the hospital segment, margin expansion potential and aggressive focus on creating digital network for pharmacy, doctor consultation, clinics and diagnostics.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.